TYVERB
Film-coated tablet, 250mg
RxActive license
Active substance (INN)
lapatinib
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength250mg
PackagingUkupno 1 bočica plastična sa 70 film tableta u kartonskoj kutiji
ManufacturerGlaxo Wellcome Operations, United Kingdom
Therapeutic groupAntineoplastic and immunomodulating agents (L01EH01)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateApril 7, 2023
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026